✦ LIBER ✦

An FDA perspective on antiarrhythmic drugs in phase II trials

✍ Scribed by Raymond Lipicky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of FDA and EMEA guidelines on

✍ Marchetti, S; Schellens, J H M 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Current perspectives on the design of ph

✍ Milton Packer 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 532 KB

An examination of the relative impact of

✍ Alan D. Hutson; Gregory E. Wilding 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Phenotype prediction of nonsynonymous si

✍ DaCheng Hao; PeiGen Xiao; ShiLin Chen 📂 Article 📅 2010 🏛 Science in China Press (SCP) 🌐 English ⚖ 680 KB

Enhancing cancer trial management: An in

✍ Eleanor Wilson; Karen Cox; Ruth Elkan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Properties of HIV envelope expressed in

✍ Barbouche, R. ;Fenouillet, E. ;Papandréou, M.-J. ;Kiény, M.P. ;Sabatier, J M. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 815 KB